Drilon warns PhilHealth of overpricing, possible graft charges

Senate Minority Leader Franklin Drilon warns PhilHealth of potential criminal liability due to alleged overpricing of COVID-19 test packages amounting to P8,150 per test.

Drilon estimates that PhilHealth could lose up to P8.3 billion if the government pushes through with its goal to test two million Filipinos at the current package rate.

He pointed out that the actual cost of a COVID-19 test, including the test kit, overhead, materials, and hospital margin, should only be around P4,000.

Drilon cited that private institutions like the Red Cross charge patients within this reasonable range for their testing services.

He expressed concern that the higher reimbursement rate by PhilHealth represents a significant overpayment and a waste of government funds, especially during a time of economic hardship.

Drilon suggested that PhilHealth executives could face charges under the Anti-Graft and Corrupt Practices Act for actions deemed detrimental to the public interest.

He stated that PhilHealth's reimbursement rate is P4,100 higher than the estimated reasonable cost per test.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

News Sources

See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.